IRONWOOD PHARMACEUTICALS, INC. Interest Expense
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Interest Expense of $7.23 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-09
- IRONWOOD PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-03-31 was $7.23M, a 373.54% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-12-31 was $8.42M, a 451.97% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $9.84M, a 545.60% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-06-30 was $1.84M, a 16.63% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for fiscal 2023 was $21.63M, a 184.67% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $7.60M, a 75.61% decline from fiscal 2021.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $31.15M, a 5.67% increase from fiscal 2020.
- IRONWOOD PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $29.48M, a 19.46% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $7.23M 10-Q · filed 2024-05-09 | $15.65M derived: sum of 2 quarters · filed 2024-05-09 | $25.49M derived: sum of 3 quarters · filed 2024-05-09 | $27.33M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | $8.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $18.26M derived: sum of 2 quarters · filed 2024-02-16 | $20.10M derived: sum of 3 quarters · filed 2024-02-16 | $21.63M 10-K · filed 2024-02-16 |
| 2023-09-30 | $9.84M 10-Q · filed 2023-11-09 | $11.68M derived: sum of 2 quarters · filed 2023-11-09 | $13.21M 10-Q · filed 2023-11-09 | $14.73M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | $1.84M 10-Q · filed 2023-08-09 | $3.37M 10-Q · filed 2023-08-09 | $4.89M derived: sum of 3 quarters · filed 2024-05-09 | $6.42M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | $1.53M 10-Q · filed 2024-05-09 | $3.05M derived: sum of 2 quarters · filed 2024-05-09 | $4.58M derived: sum of 3 quarters · filed 2024-05-09 | $6.78M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $3.05M derived: sum of 2 quarters · filed 2024-02-16 | $5.26M derived: sum of 3 quarters · filed 2024-02-16 | $7.60M 10-K · filed 2024-02-16 |
| 2022-09-30 | $1.52M 10-Q · filed 2023-11-09 | $3.73M derived: sum of 2 quarters · filed 2023-11-09 | $6.07M 10-Q · filed 2023-11-09 | $14.02M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $2.21M 10-Q · filed 2023-08-09 | $4.55M 10-Q · filed 2023-08-09 | $12.50M derived: sum of 3 quarters · filed 2024-02-16 | $20.34M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $2.34M 10-Q · filed 2023-05-04 | $10.29M derived: sum of 2 quarters · filed 2024-02-16 | $18.13M derived: sum of 3 quarters · filed 2024-02-16 | $25.86M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $15.79M derived: sum of 2 quarters · filed 2024-02-16 | $23.52M derived: sum of 3 quarters · filed 2024-02-16 | $31.15M 10-K · filed 2024-02-16 |
| 2021-09-30 | $7.84M 10-Q · filed 2022-11-03 | $15.57M derived: sum of 2 quarters · filed 2022-11-03 | $23.20M 10-Q · filed 2022-11-03 | $30.72M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $7.73M 10-Q · filed 2022-08-04 | $15.36M 10-Q · filed 2022-08-04 | $22.88M derived: sum of 3 quarters · filed 2023-02-16 | $30.30M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $7.63M 10-Q · filed 2022-05-05 | $15.15M derived: sum of 2 quarters · filed 2023-02-16 | $22.57M derived: sum of 3 quarters · filed 2023-02-16 | $29.88M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $14.94M derived: sum of 2 quarters · filed 2023-02-16 | $22.26M derived: sum of 3 quarters · filed 2023-02-16 | $29.48M 10-K · filed 2023-02-16 |
| 2020-09-30 | $7.42M 10-Q · filed 2021-11-04 | $14.74M derived: sum of 2 quarters · filed 2021-11-04 | $21.96M 10-Q · filed 2021-11-04 | $29.08M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $7.32M 10-Q · filed 2021-08-05 | $14.54M 10-Q · filed 2021-08-05 | $21.66M derived: sum of 3 quarters · filed 2022-02-18 | $32.12M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $7.22M 10-Q · filed 2021-05-06 | $14.34M derived: sum of 2 quarters · filed 2022-02-18 | $24.80M derived: sum of 3 quarters · filed 2022-02-18 | $34.23M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $17.58M derived: sum of 2 quarters · filed 2022-02-18 | $27.01M derived: sum of 3 quarters · filed 2022-02-18 | $36.60M 10-K · filed 2022-02-18 |
| 2019-09-30 | $10.46M 10-Q · filed 2020-11-05 | $19.89M derived: sum of 2 quarters · filed 2020-11-05 | $29.48M 10-Q · filed 2020-11-05 | $39.06M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $9.43M 10-Q · filed 2020-08-06 | $19.02M 10-Q · filed 2020-08-06 | $28.61M derived: sum of 3 quarters · filed 2021-02-17 | $38.09M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $9.59M 10-Q · filed 2020-05-06 | $19.18M derived: sum of 2 quarters · filed 2021-02-17 | $28.66M derived: sum of 3 quarters · filed 2021-02-17 | $38.04M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $19.07M derived: sum of 2 quarters · filed 2021-02-17 | $28.45M derived: sum of 3 quarters · filed 2021-02-17 | $37.72M 10-K · filed 2021-02-17 |
| 2018-09-30 | $9.48M 10-Q · filed 2019-10-31 | $18.86M derived: sum of 2 quarters · filed 2019-10-31 | $28.14M 10-Q · filed 2019-10-31 | $37.34M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $9.38M 10-Q · filed 2019-07-30 | $18.66M 10-Q · filed 2019-07-30 | $27.86M derived: sum of 3 quarters · filed 2020-02-13 | $37.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $9.27M 10-Q · filed 2019-05-02 | $18.48M derived: sum of 2 quarters · filed 2020-02-13 | $27.61M derived: sum of 3 quarters · filed 2020-02-13 | $36.66M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $18.34M derived: sum of 2 quarters · filed 2020-02-13 | $27.39M derived: sum of 3 quarters · filed 2020-02-13 | $36.37M 10-K · filed 2020-02-13 |
| 2017-09-30 | $9.13M 10-Q · filed 2018-11-06 | $18.18M derived: sum of 2 quarters · filed 2018-11-06 | $27.16M 10-Q · filed 2018-11-06 | $36.82M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $9.05M 10-Q · filed 2018-08-06 | $18.03M 10-Q · filed 2018-08-06 | $27.68M derived: sum of 3 quarters · filed 2019-02-25 | $37.45M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $8.98M 10-Q · filed 2018-05-04 | $18.64M derived: sum of 2 quarters · filed 2019-02-25 | $28.40M derived: sum of 3 quarters · filed 2019-02-25 | $38.23M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $19.42M derived: sum of 2 quarters · filed 2019-02-25 | $29.25M derived: sum of 3 quarters · filed 2019-02-25 | $39.15M 10-K · filed 2019-02-25 |
| 2016-09-30 | $9.77M 10-Q · filed 2017-11-02 | $19.59M derived: sum of 2 quarters · filed 2017-11-02 | $29.50M 10-Q · filed 2017-11-02 | $39.48M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $9.83M 10-Q · filed 2017-08-03 | $19.73M 10-Q · filed 2017-08-03 | $29.71M derived: sum of 3 quarters · filed 2018-02-22 | $39.74M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $9.91M 10-Q · filed 2017-05-08 | $19.89M derived: sum of 2 quarters · filed 2018-02-22 | $29.91M derived: sum of 3 quarters · filed 2018-02-22 | $35.78M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $20.00M derived: sum of 2 quarters · filed 2018-02-22 | $25.88M derived: sum of 3 quarters · filed 2018-02-22 | $31.10M 10-K · filed 2018-02-22 |
| 2015-09-30 | $10.02M 10-Q · filed 2016-11-07 | $15.89M derived: sum of 2 quarters · filed 2016-11-07 | $21.11M 10-Q · filed 2016-11-07 | $26.38M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $5.87M 10-Q · filed 2016-08-08 | $11.09M 10-Q · filed 2016-08-08 | $16.35M derived: sum of 3 quarters · filed 2017-02-22 | $21.67M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $5.22M 10-Q · filed 2016-05-10 | $10.48M derived: sum of 2 quarters · filed 2017-02-22 | $15.80M derived: sum of 3 quarters · filed 2017-02-22 | $21.10M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $10.58M derived: sum of 2 quarters · filed 2017-02-22 | $15.88M derived: sum of 3 quarters · filed 2017-02-22 | $21.17M 10-K · filed 2017-02-22 |
| 2014-09-30 | $5.32M 10-Q · filed 2015-11-05 | $10.62M derived: sum of 2 quarters · filed 2015-11-05 | $15.91M 10-Q · filed 2015-11-05 | $21.20M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $5.30M 10-Q · filed 2015-08-07 | $10.59M 10-Q · filed 2015-08-07 | $15.88M derived: sum of 3 quarters · filed 2016-02-19 | $21.15M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $5.28M 10-Q · filed 2015-05-06 | $10.58M derived: sum of 2 quarters · filed 2016-02-19 | $15.85M derived: sum of 3 quarters · filed 2016-02-19 | $21.16M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $10.56M derived: sum of 2 quarters · filed 2016-02-19 | $15.88M derived: sum of 3 quarters · filed 2016-02-19 | $21.00M 10-K · filed 2016-02-19 |
| 2013-09-30 | $5.26M 10-Q · filed 2014-11-05 | $10.58M derived: sum of 2 quarters · filed 2014-11-05 | $15.70M 10-Q · filed 2014-11-05 | $15.72M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $5.32M 10-Q · filed 2014-08-05 | $10.44M 10-Q · filed 2014-08-05 | $10.46M derived: sum of 3 quarters · filed 2015-02-18 | $10.47M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $5.12M 10-Q · filed 2014-04-29 | $5.14M derived: sum of 2 quarters · filed 2015-02-18 | $5.15M derived: sum of 3 quarters · filed 2015-02-18 | $5.17M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $32.00K derived: sum of 2 quarters · filed 2015-02-18 | $45.00K derived: sum of 3 quarters · filed 2015-02-18 | $59.00K 10-K · filed 2015-02-18 |
| 2012-09-30 | $14.00K 10-Q · filed 2013-10-28 | $27.00K derived: sum of 2 quarters · filed 2013-10-28 | $41.00K 10-Q · filed 2013-10-28 | $55.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-06-30 | $13.00K 10-Q · filed 2013-08-08 | $27.00K 10-Q · filed 2013-08-08 | $41.00K derived: sum of 3 quarters · filed 2014-02-07 | $57.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2012-03-31 | $14.00K 10-Q · filed 2013-04-23 | $28.00K derived: sum of 2 quarters · filed 2014-02-07 | $44.00K derived: sum of 3 quarters · filed 2014-02-07 | $61.00K derived: sum of 4 quarters · filed 2014-02-07 |
| 2011-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $30.00K derived: sum of 2 quarters · filed 2014-02-07 | $47.00K derived: sum of 3 quarters · filed 2014-02-07 | $63.00K 10-K · filed 2014-02-07 |
| 2011-09-30 | $16.00K 10-Q · filed 2012-11-06 | $33.00K derived: sum of 2 quarters · filed 2012-11-06 | $49.00K 10-Q · filed 2012-11-06 | $67.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $17.00K 10-Q · filed 2012-08-07 | $33.00K 10-Q · filed 2012-08-07 | $51.00K derived: sum of 3 quarters · filed 2013-02-21 | $132.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $16.00K 10-Q · filed 2012-05-10 | $34.00K derived: sum of 2 quarters · filed 2013-02-21 | $115.00K derived: sum of 3 quarters · filed 2013-02-21 | $159.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $99.00K derived: sum of 2 quarters · filed 2013-02-21 | $143.00K derived: sum of 3 quarters · filed 2013-02-21 | $196.00K 10-K · filed 2013-02-21 |
| 2010-09-30 | $81.00K 10-Q · filed 2011-11-09 | $125.00K derived: sum of 2 quarters · filed 2011-11-09 | $178.00K 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $44.00K 10-Q · filed 2011-08-12 | $97.00K 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $318.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |